JPMorgan analyst Lisa Gill assumed coverage of GoodRx with a Neutral rating and price target of $7, up from $6. The analyst believes there is “growing positivity” around the structural set up as the company fully anniversaries the Kroger disruptions and pilots Express Scripts/Caremark partnerships. However, it wants to see traction around the expected inflection to the upside for GoodRx.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on GDRX: